IO Biotech, Inc. (IOBTQ)

IO Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.66	60.03	143.19	142.59	211.53	3.41
Cash & Short-Term Investments	30.66	60.03	143.19	142.59	211.53	3.41
Cash Growth	-61.76%	-58.08%	0.42%	-32.59%	6112.36%	-
Other Current Assets	6.17	4.92	4.06	5.63	10.21	2.23
Total Current Assets	36.83	64.95	147.26	148.22	221.74	5.64
Net Property, Plant & Equipment	1.85	2.36	3.11	3.23	0.16	-
Other Long-Term Assets	1.28	0.39	0.36	0.35	0.4	0.02
Total Assets	39.96	67.7	150.72	151.81	222.29	5.65
Accounts Payable	5.59	4.66	3.88	4	3.93	0.52
Accrued Expenses	11.94	14.11	11.18	6.16	6.38	2.53
Current Portion of Leases	0.79	0.72	0.66	0.52	-	-
Total Current Liabilities	18.31	19.49	15.72	10.68	10.31	3.05
Long-Term Debt	16.66	-	-	-	-	-
Long-Term Leases	0.67	1.2	1.84	2.28	-	-
Other Long-Term Liabilities	3.4	-	-	-	0.06	-
Total Long-Term Liabilities	20.73	1.2	1.84	2.28	0.06	-
Total Liabilities	39.05	20.68	17.56	12.95	10.36	3.05
Common Stock	0.07	0.07	0.07	0.03	0.03	0.03
Additional Paid-in Capital	424.34	413.11	406.59	326.71	319.67	1.11
Accumulated Other Comprehensive Income	-7.17	-6.85	-9.67	-10.14	-1.49	1.96
Retained Earnings	-416.33	-359.31	-263.82	-177.74	-106.28	-38.4
Shareholders' Equity	0.91	47.02	133.16	138.85	211.92	-35.3
Total Liabilities & Equity	39.96	67.7	150.72	151.81	222.29	5.65
Total Debt	18.12	1.92	2.49	2.79	0	0
Net Cash (Debt)	12.55	58.12	140.7	139.8	211.53	3.41
Net Cash Growth	-78.41%	-58.70%	0.64%	-33.91%	6112.36%	-
Net Cash Per Share	0.19	0.88	3.23	4.85	48.79	19.22
Book Value	0.91	47.02	133.16	138.85	211.92	-35.3
Book Value Per Share	0.01	0.71	3.06	4.82	48.88	-199.23
Tangible Book Value	0.91	47.02	133.16	138.85	211.92	-35.3
Tangible Book Value Per Share	0.01	0.71	3.06	4.82	48.88	-199.23

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.